Cipla is planning to donate 5,000 nebulisers to primary health care centres in India as part of its initiative to improve access to nebulisation therapy specifically for patients in rural parts of the country. These nebulisers will be distributed at CHCs (community health centres) and PHCs (primary health centres) across several states.
Maharashtra, Uttar Pradesh, Rajasthan, West Bengal, Andhra Pradesh, Telangana, Tamil Nadu, Uttarakhand, Punjab, Sikkim will be adopted by Cipla to create good nebulisation centres, spread awareness regarding the therapy and undertake training for the associated paramedical staff on the science of safe nebulisation practices.
The adoption of these centres under the aegis of Cipla across the states within the country will help it reach far and wide to address the challenge of access to nebulisation therapy in India.
Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.
Bhupendra Singh Chundawat is a seasoned technology journalist with over 22 years of experience in the media industry. He specializes in covering the global technology landscape, with a deep focus on manufacturing trends and the geopolitical impact on tech companies. Currently serving as the Editor at Udaipur Kiran, his insights are shaped by decades of hands-on reporting and editorial leadership in the fast-evolving world of technology.
